Patents
Sitemap › C07 - Organic chemistry › C07H - Sugars; Derivatives thereof; Nucleosides; Nucleotides; Nucleic acids › C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
10/2010
10/28/2010WO2007028030A3 Oncogenic regulatory rnas for diagnostics and therapeutics
10/28/2010US20100275333 Abiotic stress responsive polynucleotides and polypeptides
10/28/2010US20100275327 Method of increasing abiotic stress tolerance in plants
10/28/2010US20100275326 Engineered dicotyledonous promoters capable of expressing in monocotyledonous plants
10/28/2010US20100275325 Arabidopsis promoters
10/28/2010US20100275324 Compositions and Methods for Altering Tocotrienol Content
10/28/2010US20100275323 for regulating expression of heterologous nucleotide sequences in a plant; regenerating a stably transformed plant from the transformed plant cell
10/28/2010US20100275320 Soybean sudden death syndrome resistant soybeans, soybean cyst nematode resistant soybeans and method of breeding and identifying resistant plants
10/28/2010US20100275283 Model animal in which state of disease condition is observable in real time, gene construct for achieving the same and use of the same
10/28/2010US20100275281 Multiple Inducible Gene Regulation System
10/28/2010US20100275279 Selecting animals for parentally imprinted traits
10/28/2010US20100273999 Preparation of Nucleotide Oligomer
10/28/2010US20100273998 Methods and compositions for modulating tissue factor
10/28/2010US20100273997 Ribozyme to cleave coronavirus gene
10/28/2010US20100273996 Method
10/28/2010US20100273995 Polynucleotides and their use for detecting resistance to streptogramin a or to streptogramin B and related compounds
10/28/2010US20100273981 Use of Silintaphin for the Structure-Directed Fabrication of (Nano)Composite Materials in Medicine and (Nano)Technology
10/28/2010US20100273865 Polypeptides involved in neuronal regeneration-associated gene expression
10/28/2010US20100273862 Phosphatases which activate map kinase pathways
10/28/2010US20100273861 Mycobacterial peptide deformylase
10/28/2010US20100273860 MODULATION OF APOLIPOPROTEIN (a) EXPRESSION
10/28/2010US20100273859 Treatment and prevention of hiv infection
10/28/2010US20100273858 Compositions comprising stat5 sirna and methods of use thereof
10/28/2010US20100273857 Suppression of scn9a gene expression and/or function for the treatment of pain
10/28/2010US20100273855 Compositions and methods of treating cancer
10/28/2010US20100273854 Compositions and methods for inhibiting nadph oxidase expression
10/28/2010US20100273725 Novel compounds useful in therapeutic and cosmetic methods
10/28/2010US20100273274 Polynucleotides encoding acetylcholine-gated chloride channel subunits of caenorhabditis elegans
10/28/2010US20100273257 Apo-2DcR
10/28/2010US20100273255 Human micrornas and methods for inhibiting same
10/28/2010US20100273237 Processes for Packaging Oligonucleotides Into Virus-Like Particles of RNA Bacteriophages
10/28/2010US20100273232 Methods for cloning small rna species
10/28/2010US20100273226 Isolated polynucleotide for increasing alcohol tolerance of host cell, vector and host cell containing the same, and method of producing alcohol using the same
10/28/2010US20100273225 Expression cassette for lactase dehydrogenase, transformed yeast and method of producing lactic acid
10/28/2010US20100273223 New Calb Muteins and Their Use
10/28/2010US20100273220 Innate immune suppression enables repeated delivery of long rna molecules
10/28/2010US20100273215 Secretion Yield of a Protein of Interest by in vivo Proteolytic Processing of a Multimeric Precursor
10/28/2010US20100273212 PP1 Ligands
10/28/2010US20100273202 Codon-optimized nucleic acid for coding apo-clytin-ii and method for using the same
10/28/2010US20100273201 Acetolactate Synthase (ALS) Selectable Marker from Trichoderma reesei
10/28/2010US20100273194 Immunoreactive ehrlichia p120/p140 epitopes and uses thereof
10/28/2010US20100273193 Triacetone Triperoxide and Diacetone Diperoxide Derivatives, Method for the Preparation and Use Thereof
10/28/2010US20100273187 Antibodies against delta-5 desaturase and uses thereof
10/28/2010US20100273186 Split mutant hydrolase fusion reporter and uses thereof
10/28/2010US20100273180 Decorin polypeptide and methods and compositions of use thereof
10/28/2010US20100273176 Method of judging risk for onset of drug-induced granulocytopenia
10/28/2010US20100273175 Method of judging risk for onset of drug-induced granulocytopenia
10/28/2010US20100273173 Method for amplifying target nucleic acid sequence and probe used for the same
10/28/2010US20100273169 Quantitative pcr-based compositions and methods for the diagnosis of invasive pulmonary aspergillosis
10/28/2010US20100273167 Methods for determining prenatal alcohol exposure
10/28/2010US20100273165 Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non invasive prenatal diagnoses
10/28/2010US20100273163 Methods for Identifying Agents that Inhibit Cell Migration, Promote Cell Adhesion and Prevent Metastasis
10/28/2010US20100273161 Detection of bacteria belonging to the genus campylobacter by targeting cytolethal distending toxin
10/28/2010US20100273156 Sequences and methods for detecting influenza a and influenza b virus
10/28/2010US20100273154 Novel glycosyltransferases and polynucleotides encoding the same
10/28/2010US20100273152 Method of identifying individuals at risk of thiopurine drug resistance and intolerance
10/28/2010US20100273150 Single molecule-format bioluminescent probe
10/28/2010US20100273146 TB resistance assay
10/28/2010US20100273145 Assay method utilizing polynucleotide sequences
10/28/2010US20100273143 Discriminatory positive/extraction control dna
10/28/2010US20100272855 Hybrid alpha-glucoside transporter
10/28/2010US20100272757 Bacillus anthracis protective antigen nucleic acid sequences
10/28/2010US20100272751 Truncated l1 protein of human papillomavirus type 18
10/28/2010US20100272750 Hpv polyepitope constructs and uses thereof
10/28/2010US20100272743 Staphylococcus epidermidis nucleic acids and proteins
10/28/2010US20100272738 Anti-ox40l antibodies and methods using same
10/28/2010US20100272734 Compositions and methods for increasing muscle growth
10/28/2010US20100272733 Antibodies specific to pro-angiogenic isoforms of vascular endothelial growth factor (vegf)
10/28/2010US20100272730 Antigenic GM-CSF Peptides And Antibodies To GM-CSF
10/28/2010US20100272726 Assays, methods and means
10/28/2010US20100272725 Neisserial antigens
10/28/2010US20100272724 Binding molecules capable of neutralizing rabies virus and uses thereof
10/28/2010US20100272723 Optimized Antibodies that Target CD19
10/28/2010US20100272722 Therapeutic uses of inhibitors of RTP801
10/28/2010US20100272720 Antibody Fusion Proteins with a Modified FcRn Binding Site
10/28/2010US20100272716 Antibodies to VLA-1
10/28/2010US20100272640 Monoclonal Antibodies Against PCBP-1 Antigens, and Uses Therefor
10/28/2010US20100272639 Polysaccharide nanoparticles
10/27/2010EP2243834A1 Assessment of risk for colorectal cancer
10/27/2010EP2243787A2 Peptides binding the phosphatase 2a protein and polynucleotides encoding same
10/27/2010EP2243786A1 Oligonucleotides against HIV infection and its application in the prevention and treatment of acquired immune deficiency syndrome
10/27/2010EP2242875A1 Protein c rs2069915 as a response predictor to survival and administration of activated protein c or protein c-like compound
10/27/2010EP2242761A1 Method of mycotoxin detection
10/27/2010EP1692160B1 Fgf-5 binding and supported peptides
10/27/2010EP1601970B1 Detection, monitoring and treatment of cancer
10/27/2010EP1276752B1 Method of evaluating a risk of a subject of developing vascular complications
10/27/2010EP0979101B1 Recombinant canine adenovirus 2 (cav2) containing exogenous dna
10/27/2010CN1912141B Identification of genes
10/27/2010CN101874119A 3.4 kb mitochondrial DNA deletion for use in the detection of cancer
10/27/2010CN101874112A Nucleic acid of formula I): GlXmGn, or (II): ClXmCn, in particular as an immune-stimulating agent/adjuvant
10/27/2010CN101873867A High concentration chitosan-nucleic acid polyplex compositions
10/27/2010CN101870717A Oligonucleotide direct condensation method reagent and application thereof
10/26/2010US7820890 Inbred corn line G07-NPXA6496
10/26/2010US7820882 Overexpression of a NAC coding sequence can accelerate senescence and increase grain protein content ; delaying senescence in a wheat plant by inhibiting expression of an endogenous WNAC gene in the plant
10/26/2010US7820810 Process for the synthesis of 2′-O-substituted purine nulceosides
10/26/2010US7820809 Short interfering RNA sequences for use in the treatment and prevention of diabetes, alzheimer's and cancer; gene expression inhibition
10/26/2010US7820808 Antisense agent which prevents DNA replication
10/26/2010US7820805 Sulfotransferase 2B1 pharmacogenetics
10/26/2010US7820783 Contain chemically reactive carbocyanine dyes that are intramolecularly crosslinked between the 1-position and 3'-position, their bioconjugates
10/26/2010US7820633 cytotoxic T-cell mediated killing of disease cells that express a weakly immunogenic or non-immunogenic cell-associated polypeptide antigen in an animal by administering a cytotoxic T-cell epitope and a T-helper lymphocyte
1 ... 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 ... 899